Economic and Health-Related Quality of Life Considerations of New Therapies in Parkinson’s Disease

@article{Rubenstein2001EconomicAH,
  title={Economic and Health-Related Quality of Life Considerations of New Therapies in Parkinson’s Disease},
  author={Dr Linda M. Rubenstein and Andrea J. DeLeo and Elizabeth A. Chrischilles},
  journal={PharmacoEconomics},
  year={2001},
  volume={19},
  pages={729-752}
}
The progressive disability of Parkinson’s disease results in substantial burdens for patients, their families and society in terms of increased health resource use, poorer quality of life, caregiver burden, disrupted family relationships, decreases in social and leisure activities, deteriorating emotional well-being, and direct and indirect costs of illness.Health-related quality of life (HR-QOL) measures have been used successfully in cross-sectional studies to identify and characterise these… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

The long‐term direct and indirect economic burden among Parkinson's disease caregivers in the United States

  • Movement disorders : official journal of the Movement Disorder Society
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

The attributable annual health costs of U.S. occupational lead poisoning

  • International journal of occupational and environmental health
  • 2016

References

Publications referenced by this paper.
SHOWING 1-10 OF 225 REFERENCES

Coping with disease-related stressors in Parkinson's disease.

  • The Gerontologist
  • 2000
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

The health burdens of Parkinson's disease.

  • Movement disorders : official journal of the Movement Disorder Society
  • 1998
VIEW 13 EXCERPTS

Quality of life and care in Parkinson's disease.

  • The British journal of clinical practice
  • 1995
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL